Oncology innovations and cancer care treatment are complex, exceeding an estimated $200 billion in 2020. As cancer research constantly develops new...
The complexity of cancer care continues to increase, and payers are under pressure to balance the dramatic rise in costs...
The pandemic has forced us as an industry to reexamine how we interact and engage with our patients and how...
Learn how payers can reduce and manage the costs of cancer while driving positive outcomes for their members, their provider...
The burden of cancer and autoimmune diseases is heavy on patients, providers, and payers in the United States. Nearly 40...
Prostate cancer killed my dad. Liver cancer killed his father. My mom is fighting multiple myeloma. Her mother battled breast...
For over ten years, Eviti Connect has empowered oncology practices and health plans to prescribe and reimburse high-quality, high-value patient care....
We are excited about the recent launch of Eviti Connect® for autoimmune diseases, aimed at helping payers and providers realize...
As oncology costs continue to escalate and treatment decisions are more complex than ever, Eviti Connect empowers providers and payers...
Many factors go into making an informed treatment decision. Eviti Advisor supports physicians in the treatment decision process using a...
The cost of oncology-focused drugs in the U.S. has now exceeded $56 billion and the median annual expense of a new cancer...
There is no doubt that COVID-19 has had a tremendous impact on the U.S. healthcare system, forcing everyone—from payers to...